低与高CO2清除能力装置实现超保护性通气的疗效与安全性比较:SUPERNOVA研究二次分析
结果显示高清除能力装置更常达到目标潮气量且不良事件更少。
要点
- 高CO2清除能力装置更常实现4 mL/kg潮气量且不良事件更少
- 低清除能力装置ECCO2R相关溶血与出血发生率更高
- 选择ECCO2R装置时应考虑CO2清除能力以平衡疗效与安全性
核心结论
- 高CO2清除能力装置更频繁实现4 mL/kg潮气量且不良事件发生率更低。
主要发现
- 基线后8小时和24小时达到潮气量4 mL/kg的患者比例:低清除能力装置组分别为55%和64%,高清除能力装置组分别为90%和92%(p<0.001)。
- ECCO2R相关溶血发生率低清除能力装置组为21%,高清除能力装置组为6%(p=0.045)。
- ECCO2R相关出血发生率低清除能力装置组为27%,高清除能力装置组为6%(p=0.010)。
关键数值与推荐
- 低清除能力装置:膜面积0.59 m2,血流量300-500 mL/min。
- 高清除能力装置:膜面积1.30 m2,血流量800-1000 mL/min。
临床怎么用
- 在ARDS患者中以ECCO2R辅助实现4 mL/kg超保护性通气时,优先选择CO2清除能力较高的装置可能提高达标率并减少溶血与出血。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Retrospective analysis of the SUPERNOVA trial exploring the hypothesis that efficacy and safety of extracorporeal carbon dioxide removal (ECCO2R) to facilitate reduction of tidal volume (VT) to 4 mL/kg in patients with acute respiratory distress syndrome (ARDS) may differ between systems with lower (area of membrane length 0.59 m2; blood flow 300-500 mL/min) and higher (membrane area 1.30 m2; blood flow between 800 and 1000 mL/min) CO2 extraction capacity. Ninety-five patients with moderate ARDS were included (33 patients treated with lower and 62 patients treated with higher CO2 extraction devices). We found that (1) VT of 4 mL/kg was reached by 55% and 64% of patients with the lower extraction versus 90% and 92% of patients with higher extraction devices at 8 and 24 hours from baseline, respectively (p<0.001), and (2) percentage of patients experiencing episodes of ECCO2R-related haemolysis and bleeding was higher with lower than with higher extraction devices (21% vs 6%, p=0.045% and 27% vs 6%, p=0.010, respectively). Although V T of 4 mL/kg could have been obtained with all devices, this was achieved frequently and with a lower rate of adverse events by devices with higher CO2 extraction capacity.
引用
- Combes A, Tonetti T, Fanelli V, et al. Efficacy and safety of lower versus higher CO2 extraction devices to allow ultraprotective ventilation: secondary analysis of the SUPERNOVA study. Thorax. 2019. PMID: 31409646. doi:10.1136/thoraxjnl-2019-213591
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。